All In Biotech

Free tool

FAERS Monitor: Bortezomib

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206927 or its brand name (Bortezomib, Bortezomib). Reports on generic versions are filed under their own applications.

Reports

33,996

Serious

32,180

95% of reports

Hospitalization

10,537

Death reported

6,006

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • plasma cell myeloma5,249
  • off label use3,253
  • drug ineffective2,307
  • neuropathy peripheral1,904
  • thrombocytopenia1,807
  • death1,591
  • pneumonia1,575
  • neutropenia1,428
  • diarrhoea1,414
  • fatigue1,162
  • anaemia1,136
  • disease progression1,072
  • pyrexia980
  • nausea925
  • toxicity to various agents918

Reports by year received

View as table
YearReports
200415
200525
200617
200737
200878
2009161
2010248
2011313
2012409
2013556
2014800
20151,311
20161,077
20171,232
20181,699
20192,521
20203,037
20213,110
20223,923
20233,918
20243,760
20253,243
20262,506

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,163 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal5,24996.093.4427,871
neuropathy peripheralSignal1,90412.612.120,035
thrombocytopeniaSignal1,80710.19.714,725
neutropeniaSignal1,4286.66.26,691
disease progressionSignal1,0725.65.34,081
anaemiaSignal1,1363.73.52,244
toxicity to various agentsSignal9183.43.21,541
pneumoniaSignal1,5753.02.92,148
off label useSignal3,2532.32.22,492
pyrexia9801.81.6322
diarrhoea1,4141.41.3136
death1,5911.11.129
drug ineffective2,3071.11.016
fatigue1,1620.90.98
nausea9250.70.7102

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.